Blog

Groove pancreatitis is a rare form of chronic pancreatitis that affects the groove between the head of the pancreas, the duodenum, and the common bile duct. It produces a mass-like thickening in that specific area that looks alarmingly like pancreatic head cancer on CT and MRI. Most patients we see with this condition spent weeks or months being worked up for suspected malignancy before someone considered groove pancreatitis as the actual diagnosis. Almost always linked to heavy alcohol use and usually presents with upper abdominal pain, nausea, vomiting, and weight loss that makes the cancer suspicion feel even more convincing. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Groove pancreatitis is one of the most commonly misdiagnosed pancreatic conditions because it sits in exactly the location where pancreatic cancer appears and produces imaging findings that even experienced radiologists struggle to distinguish from malignancy without proper EUS evaluation.” What Causes Groove Pancreatitis and How Is It Diagnosed? Alcohol is behind most cases. But the diagnosis is tricky because everything about it looks like cancer until you prove otherwise. Alcohol: Chronic heavy drinking is the primary driver in most cases we diagnose. The inflammation concentrates specifically in the groove between the pancreatic head and the duodenum rather than affecting the whole organ, and that focal pattern is exactly what makes it look like a mass on imaging rather than diffuse pancreatitis that’s easier to recognise. Mechanism: Repeated alcohol-induced inflammation damages the minor papilla area, causes protein plugs and cystic changes in the duodenal wall, fibrosis develops in the groove, and over time the whole area thickens into what looks like a solid mass on CT. The duodenal wall itself gets involved. That’s unusual for standard pancreatitis and it’s one of the features that distinguishes groove pancreatitis from other forms. Mimics Cancer: CT and MRI show a mass in the pancreatic head region with duodenal wall thickening, bile duct narrowing, and sometimes cystic changes. Looks like cancer. Radiologist reports it as suspicious. Surgeon gets consulted. Patient is terrified. And in a proportion of cases, the whole thing turns out to be inflammatory. The problem is that nobody can be 100% certain without tissue, and that’s where EUS comes in. Diagnosis: EUS gets close enough to see the groove in detail that external imaging can’t match, characterises the tissue pattern, identifies the cystic changes within the duodenal wall that are more typical of groove pancreatitis than cancer, and provides FNA biopsy of the thickened area. Biopsy showing fibrosis and inflammation without malignant cells is what finally settles the question for most patients. Getting this diagnosis right avoids unnecessary surgery. Specialist in endoscopic ultrasound differentiates groove pancreatitis from pancreatic cancer using tissue-level detail that CT and MRI can suggest but never confirm. How Is Groove Pancreatitis Treated? Treatment depends on how severe the symptoms are and whether complications like duodenal obstruction or bile duct compression have developed. Conservative: Alcohol cessation is the foundation. Pain management. Nutritional support. In mild to moderate cases the inflammatory process stabilises and sometimes partially regresses once alcohol is removed from the picture. Patients who stop drinking early enough often avoid any procedural intervention entirely, and that’s a genuinely different outcome from what they were expecting when they walked in thinking they had cancer. Endoscopic: Bile duct compression from groove inflammation managed with ERCP stenting. Duodenal stenosis dilated endoscopically when obstruction develops. Pain from ductal involvement addressed through stenting or celiac plexus block. These interventions manage complications without surgery and buy time for conservative treatment to work in patients who’ve committed to alcohol cessation. Surgery: Reserved for patients with refractory pain despite conservative and endoscopic management, or when malignancy genuinely cannot be excluded even after EUS and biopsy. Pancreaticoduodenectomy is the standard surgical approach but it’s a major operation for a benign condition, and the decision to operate should only happen after every reasonable attempt to confirm the diagnosis non-surgically has been exhausted. Monitoring: Even after diagnosis, these patients need follow-up imaging to ensure the inflammation is regressing with conservative treatment and not progressing. And honestly, because groove pancreatitis and pancreatic cancer can look identical even on EUS in some cases, ongoing surveillance gives the clinical team and the patient a safety net that a single investigation never provides. Groove pancreatitis is treatable and usually benign. The challenge is getting the diagnosis right before surgery happens. Read more on duct strictures to understand how duct-level changes in chronic pancreatitis overlap with findings in groove pancreatitis and why characterisation matters. Why Choose Dr. Vipulroy Rathod for Groove Pancreatitis Diagnosis? Dr. Vipulroy Rathod has spent over 30 years differentiating unusual pancreatic conditions from malignancy at Fortis Hospital Mulund. Groove pancreatitis diagnosed through EUS in patients referred for Whipple surgery they didn’t need. Malignancy confirmed in cases that looked inflammatory but weren’t. EUS since 1998. 35 countries worth of physicians trained in exactly this kind of diagnostic distinction. Patients arrive having been told they likely have pancreatic cancer based on a CT report. Some of them leave with a groove pancreatitis diagnosis, a conservative management plan, and their pancreas still intact. That’s a different life from the one they were preparing for.   Book your consultation today with one of India’s most experienced specialists for groove pancreatitis diagnosis and management. Book Appointment Call now Frequently Asked Questions What is the difference between groove pancreatitis and pancreatic cancer? Groove pancreatitis is a benign inflammatory condition affecting the groove near the pancreatic head while pancreatic cancer is malignant, but both produce similar mass-like findings on imaging. Can groove pancreatitis be treated without surgery? Yes, most cases respond to alcohol cessation, pain management, and endoscopic intervention for complications without requiring surgical resection. How is groove pancreatitis diagnosed accurately? EUS with fine needle aspiration biopsy provides the most accurate differentiation from pancreatic cancer by showing inflammatory tissue patterns and excluding malignant cells. Is groove pancreatitis caused by alcohol? Chronic heavy alcohol use is the primary risk factor for groove pancreatitis in most diagnosed cases. Reference links- Groove

Liver cirrhosis is a progressive condition in which healthy liver tissue is gradually replaced by scar tissue, reducing the organ’s ability to function. It develops over several years and often shows no clear signs in its early phases. Because the damage progresses slowly, many patients remain unaware of the condition until it advances. Stage 3 liver cirrhosis represents a critical phase where the scarring becomes severe and the liver begins to struggle with essential functions. At this stage, complications such as fluid accumulation and bleeding risks often start to appear, making timely medical attention important for managing the condition effectively. Dr. Vipulroy Rathod, a highly respected gastroenterologist in Mumbai, India, highlights, “Stage 3 cirrhosis is the phase where complications begin to surface, so close monitoring becomes essential.” He further adds, “While the scarring cannot be reversed, the right treatment approach can slow progression and improve quality of life significantly.”    Dr. Rathod is widely recognized for his expertise in managing complex liver and digestive disorders. With considerable experience in advanced diagnostic and therapeutic procedures, he focuses on controlling complications and preserving liver function for as long as possible. His approach to stage 3 liver cirrhosis centres on early detection of complications, individualised treatment planning, and consistent follow-up, helping patients maintain stability and avoid rapid deterioration. What Causes Stage 3 Liver Cirrhosis? Stage 3 cirrhosis develops when ongoing liver damage continues without adequate treatment. Several underlying conditions contribute to this advanced scarring. Common causes include: Chronic alcohol use: Long-term heavy drinking progressively damages liver cells. Viral hepatitis: Hepatitis B and C infections cause persistent inflammation that leads to scarring. Fatty liver disease: Fat accumulation, often linked to obesity and diabetes, gradually harms the liver. Autoimmune conditions: In some patients, the immune system mistakenly attacks healthy liver tissue. Bile duct disorders: Blockage or injury to the bile ducts can trigger chronic liver damage. Identifying the underlying cause is key to slowing progression and planning effective treatment. How Is PEI Diagnosed and Treated? Diagnosis takes one test. Treatment takes one medication. The problem is neither happens for months because nobody considers the pancreas until everything else has been tried first. Fecal Elastase: Stool sample. Result in 48 hours. Below 200 is moderate. Below 100 is severe. That’s it. One test. Would have saved the patient months of elimination diets, probiotics, and frustration if someone had ordered it at the first appointment. PERT: Enzyme replacement capsules with every meal and snack. Start at 40,000 to 50,000 units lipase per main meal, 25,000 per snack. Most patients feel genuinely different within 2 to 4 weeks. Stools normalise. Bloating drops. Weight starts recovering. They ask why nobody started this sooner. Vitamins: A, D, E, K can’t absorb without lipase. Check levels. Supplement what’s low. Patient comes in with bone pain from D deficiency, bruising from K, fatigue nobody explained. Put those findings next to oily stools and weight loss and the diagnosis writes itself. Cause: PERT fixes the symptom. Doesn’t fix the patient. Chronic pancreatitis needs managing. Cancer needs ruling out. Surgical patients need monitoring. Enzyme capsules without investigating why the pancreas stopped working is like treating a fever without looking for the infection. PEI responds to treatment quickly when diagnosed properly. Read more on enzyme deficiency signs to understand which specific symptoms should trigger testing and how dose titration works in real clinical practice. Noticing unusual symptoms or have a history of liver issues? Connect with a specialist to assess your liver health and next steps. Book Appointment Call now Common Symptoms of Stage 3 Liver Cirrhosis Symptoms become more noticeable at this stage as liver function declines and complications begin to develop. Common symptoms include: Fluid accumulation in the abdomen (ascites), causing swelling and discomfort Jaundice, with yellowing of the skin and eyes Easy bruising and bleeding due to impaired clotting Persistent fatigue and general weakness Swelling in the legs and ankles (edema) Confusion or difficulty concentrating, in some cases “Recognising symptoms such as ascites or jaundice early can prevent complications and ensure better outcomes,” states Dr. Vipulroy Rathod. Liver biopsy Confirms the severity of cirrhosis when required Blood tests Assess liver function, clotting ability, and help identify the underlying cause Ultrasound: Visualises the liver structure and detects fluid accumulation CT scan or MRI Provides detailed imaging of the damage and any complications Together, these tests provide a clear picture of the condition and guide appropriate treatment. Treatment Options for Stage 3 Liver Cirrhosis   Since the scarring cannot be reversed, treatment focuses on slowing progression, managing complications, and addressing the underlying cause. The treatment options include: · Treating the Underlying Cause This may involve antiviral medication for hepatitis or complete cessation of alcohol, both of which help prevent further liver damage. · Managing Fluid Retention Diuretics and a low-salt diet are used to control ascites and swelling, with fluid drainage performed in severe cases. · Controlling Bleeding Risks Medications and endoscopic procedures help manage enlarged varices and reduce the risk of dangerous bleeding. · Nutritional Support A carefully planned diet supports liver function and addresses the malnutrition common at this stage. · Medications for Complications Specific medications are prescribed to manage hepatic encephalopathy and prevent infections. · Regular Monitoring Frequent checkups and screening help detect complications early and track the progression of the condition. · Liver Transplant Evaluation In advanced cases where the liver fails to function adequately, transplant evaluation may be considered as a long-term solution. Early and appropriate treatment significantly improves quality of life and reduces the risk of serious complications. What happens if stage 3 cirrhosis is left untreated? Let’s understand the potential risks. Complications if Stage 3 Cirrhosis is Left Untreated Without proper control, stage 3 liver cirrhosis can worsen and cause fatal outcomes. Complications that can develop include: Complete liver failure with development of stage 4 cirrhosis Internal bleeding due to varices rupturing Severe fluid accumulation in the abdomen and infections Changes in brain function due to hepatic encephalopathy Strong possibility of there being liver cancer Intervening

Pancreatic duct blockage is treated endoscopically in most cases through ERCP, where stones are removed, strictures are stented, and enzyme drainage gets restored without any surgical incision. The duct gets blocked by stones from chronic pancreatitis, by scar tissue narrowing the lumen over years, by tumours compressing from outside, or by mucus plugs in certain cystic conditions. What caused the blockage determines how it gets treated, and getting that wrong means the patient either gets too much intervention or not enough. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Pancreatic duct blockage is treatable endoscopically in most patients we see, but the key is knowing what’s causing the obstruction before choosing the intervention, because a stone needs extraction, a stricture needs stenting, and a tumour needs tissue diagnosis before anyone does anything else.” What Causes Pancreatic Duct Blockage? Four main causes. Each one needs a different approach. Treating them all the same way is where things go wrong. Stones: Chronic pancreatitis produces calcifications inside the pancreatic duct over time. Small ones pass on their own sometimes. Larger ones lodge in the duct, block enzyme flow completely, build up ductal pressure, and the patient gets pain that worsens after meals because the enzymes have nowhere to go. We see this pattern constantly in patients with a long drinking history who’ve had multiple pancreatitis episodes nobody connected together. Strictures: Scar tissue from repeated inflammation narrows the duct progressively until flow drops below what the gut needs for digestion. Different from stones because the narrowing is in the wall itself not sitting inside the lumen, and stenting works differently here than stone extraction does, different tool, different technique, different follow-up plan. Tumours: Pancreatic head mass or ampullary tumour compressing the duct from outside. Duct blockage is sometimes the first presentation of pancreatic cancer, patient comes in with pain and enzyme deficiency and imaging finds a mass nobody was looking for. This is why every duct blockage needs proper characterisation before treatment starts, not after. Mucus: Intraductal papillary mucinous neoplasms produce thick mucus that blocks the duct intermittently. Symptoms come and go. Imaging shows duct dilation with mucus filling. IPMN itself carries malignant potential, so the blockage is actually the less dangerous problem compared to what the IPMN might become if nobody monitors it. Multiple causes can coexist in the same patient. Specialists in pancreatitis treatment identify what’s driving the obstruction before deciding on the intervention approach. How Is Pancreatic Duct Blockage Treated Without Surgery? Endoscopic treatment handles most cases. Surgery is backup, not first line, and patients who end up in surgery often got there because endoscopic options weren’t tried properly first. ERCP Stone Extraction: Scope passes through the mouth into the duodenum, accesses the pancreatic duct, stones pulled out with baskets or balloons, larger stones broken up with lithotripsy first then extracted. Patient goes home next day in most cases. Pain relief is often immediate because the pressure that was building behind the stone releases the moment the stone comes out. Stenting: Plastic or metal stent placed across a stricture to hold the duct open and restore flow. Single stent for short strictures. Multiple simultaneous stents exchanged every few months for 12 to 18 months for longer fibrotic strictures. Takes time and follow-up but avoids surgery in a meaningful proportion of patients who would otherwise have been referred for a Puestow or Frey. Lithotripsy: Stones too large for direct ERCP extraction broken up with extracorporeal shock wave lithotripsy first, fragments then removed endoscopically. Not every centre has this. Patients get referred to surgery for large stones that could have been fragmented and extracted endoscopically if the right equipment and expertise were available. EUS-Guided Drainage: When the duct is completely obstructed and ERCP access isn’t possible, EUS-guided rendezvous or direct transmural drainage creates a new pathway for enzyme flow. Advanced technique. Not widely available. But for patients who’ve failed ERCP and are facing surgery as the only option, this is sometimes the intervention that keeps them out of the operating theatre. Most duct blockages are manageable endoscopically when the right expertise and equipment exist in the same room. Read more on duct strictures to understand how stricture-specific treatment differs from stone extraction and why the distinction matters for outcomes. Why Choose Dr. Vipulroy Rathod for Pancreatic Duct Blockage Treatment? Dr. Vipulroy Rathod has spent over 30 years treating pancreatic duct blockages through ERCP, lithotripsy, stenting, and EUS-guided drainage at Fortis Hospital Mulund. Stones extracted that other centres referred to surgery. Strictures stented and resolved over months of structured follow-up. Tumour-related blockages diagnosed through EUS biopsy before treatment went in the wrong direction. 35 countries worth of physicians trained in this endoscopic approach. Patients arrive with pancreatic pain that hasn’t responded to anything because nobody addressed the mechanical obstruction causing it. Most leave with the duct reopened and the cause identified in the same workup.   Book your consultation today with one of India’s most experienced specialists for pancreatic duct blockage diagnosis and endoscopic treatment. Book Appointment Call now Frequently Asked Questions What is the most common cause of pancreatic duct blockage? Pancreatic duct stones from chronic pancreatitis are the most common cause of duct blockage in adults. Can pancreatic duct blockage be treated without surgery? Yes, ERCP with stone extraction or stent placement treats most pancreatic duct blockages endoscopically without surgical intervention. How quickly does pain improve after pancreatic duct blockage treatment? Pain relief is often immediate after stone extraction and within days after stent placement as ductal pressure normalises. What happens if pancreatic duct blockage is not treated? Untreated blockage leads to chronic pain, pancreatic enzyme deficiency, malnutrition, and increased risk of pancreatic damage and complications. Reference links- Pancreatic Duct Obstruction Management — American Society for Gastrointestinal Endoscopy ERCP in Pancreatic Disease — World Gastroenterology Organisation

A pancreatic duct stricture is a narrowing inside the main pancreatic duct that blocks digestive enzymes from reaching the small intestine. Chronic pancreatitis causes most of them, scar tissue builds up inside the duct wall over years of inflammation, the opening shrinks, enzymes back up, pressure builds, and the patient gets pain that no amount of medication touches because the problem is a physical blockage not inflammation anymore. Some strictures are benign scarring. Some are a tumour pressing on the duct from outside. Telling those apart is the single most important step before anything else happens. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “A pancreatic duct stricture is not a diagnosis by itself, it’s a finding that needs characterising because the difference between a benign inflammatory stricture and a malignant one changes everything about what happens next for the patient.” What Causes Pancreatic Duct Strictures? Several things narrow the duct. Some destroy from inside. Some compress from outside. Doesn’t matter how, the gut can’t work without enzyme flow. Pancreatitis: Most common cause we see in practice. Years of inflammation replacing functional tissue with scar. Duct narrows progressively. Pain comes and goes at first, then becomes constant. Here’s what catches people off guard though, by the time symptoms are obvious enough to investigate, the stricture has usually been building for years because the pancreas masked early damage with its functional reserve. Cancer: Tumour pressing on the duct from outside or growing into the wall produces a stricture that sometimes looks similar to scarring on CT. Sometimes. Not always. And that “sometimes” is exactly where patients end up on the wrong treatment path because CT couldn’t tell the difference and nobody ordered EUS with biopsy to settle the question properly. Autoimmune: IgG4-related autoimmune pancreatitis. Duct narrowing that looks like cancer on imaging. Responds dramatically to steroids. Misdiagnose this as malignancy and the patient gets a Whipple they never needed. Miss it completely and the stricture progresses while nobody treats what’s actually driving it. Both outcomes are bad. Diagnosis: MRCP maps duct anatomy non-invasively. EUS gets close enough to see wall detail and biopsy suspicious areas in the same session. ERCP can diagnose and treat simultaneously by stenting across the stricture while collecting brushings. The investigation that gets ordered first often determines whether the patient gets the right answer quickly or spends months in diagnostic limbo. Getting the cause right before treatment starts is the whole game. Specialist in endoscopic ultrasound characterises the stricture properly before anything else moves forward. How Are Pancreatic Duct Strictures Treated? Depends entirely on benign versus malignant. Get that distinction wrong and everything that follows goes in the wrong direction. Stenting: For benign strictures from chronic pancreatitis, ERCP places a stent across the narrowing to restore enzyme drainage. Most patients notice pain dropping within days. Not gradually over weeks. Days. Because the mechanical problem causing the pain has been physically opened and the pressure that was building behind the stricture releases immediately. Multiple Stents: One stent doesn’t always resolve a fibrotic stricture permanently. Current approach is placing multiple plastic stents simultaneously, exchanging them every 3 to 6 months for 12 to 18 months, gradually remodelling the duct. Works in a meaningful proportion of patients. Avoids surgery. Takes patience and follow-through from both the doctor and the patient. Surgery: Endoscopic stenting fails or stricture keeps coming back despite proper therapy. That’s when surgical drainage through a Puestow or Frey procedure becomes the right call. But only after genuine endoscopic failure. Not after one stent that nobody followed up. Not after three months of waiting without a plan. After a real structured endoscopic attempt that was given a proper chance to work. Malignant: Stent placed for palliation to restore enzyme and bile flow. Primary treatment is oncological. Chemo, radiation, or surgery depending on staging. The stent buys time and quality of life while systemic treatment runs. It doesn’t treat the cancer. It keeps the patient functional while the cancer gets treated. Stricture treatment works when the cause is identified first. Read more on pancreatitis without surgery to understand how duct stricture management fits into the broader non-surgical pancreatitis treatment picture. Why Choose Dr. Vipulroy Rathod for Pancreatic Duct Stricture Management? Dr. Vipulroy Rathod has spent over 30 years managing pancreatic duct strictures at Fortis Hospital Mulund. Benign strictures treated endoscopically that other centres sent straight to surgery. Malignant strictures identified through EUS biopsy when CT left the question open. Autoimmune strictures caught before unnecessary operations happened. 35 countries worth of physicians trained in this specific endoscopic approach. Patients arrive with persistent pancreatic pain that medication hasn’t touched for months. Most leave with a duct that’s been opened, a cause that’s been identified, and symptoms resolving in ways they’d stopped expecting.   Book your consultation today with one of India’s most experienced specialists for pancreatic duct stricture diagnosis and endoscopic treatment. Book Appointment Call now Frequently Asked Questions What causes a pancreatic duct stricture? Chronic pancreatitis is the most common cause, with scar tissue narrowing the duct over years of repeated inflammation. Can a pancreatic duct stricture be treated without surgery? Yes, most benign strictures are treated through ERCP with stent placement that restores enzyme drainage without surgical intervention. How do doctors tell if a pancreatic duct stricture is cancerous? EUS with fine needle aspiration biopsy of the stricture area provides tissue diagnosis that distinguishes benign from malignant strictures. How long does stent treatment for pancreatic duct stricture take? Multiple stent exchanges over 12 to 18 months are typically needed to achieve long-term resolution of benign pancreatic duct strictures. Reference links- Pancreatic Duct Stricture Management — American Society for Gastrointestinal Endoscopy Chronic Pancreatitis Duct Stricture Guidelines — World Gastroenterology Organisation

Pancreatic exocrine insufficiency is what you get when the pancreas can’t make enough enzymes to digest food. Lipase, protease, amylase, all of them drop. Fat goes through unabsorbed, protein follows, and the patient ends up malnourished while eating three meals a day. Chronic pancreatitis causes most cases we see. Cancer, surgery, even long-standing diabetes can do it too. And the frustrating part is how long it takes to diagnose, because the symptoms look identical to IBS on paper and nobody orders a fecal elastase until somebody finally thinks of it. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “PEI is underdiagnosed because the symptoms look like half a dozen other GI conditions and most clinicians don’t test pancreatic function unless they already suspect pancreatic disease, so the patients who need enzyme replacement the most are exactly the ones who wait the longest to get it.” What Causes Pancreatic Exocrine Insufficiency? Several things break the enzyme-producing machinery. Some destroy tissue. Some block delivery. Doesn’t matter how it happens, the gut can’t digest without enzymes. Pancreatitis: Most common cause in adults. Years of inflammation replacing functional acinar cells with scar tissue. Here’s the thing though, by the time PEI symptoms show up clinically, 90% of exocrine function is already gone because the pancreas has enough reserve to mask early damage, so patients feel fine until they suddenly don’t. Cancer: Tumour blocks the main duct or eats into enzyme-producing tissue directly. PEI showing up with weight loss in a patient over 50 should always trigger imaging. Always. Because the enzyme deficiency might be the first clue that something worse is sitting underneath and starting PERT without investigating is incomplete. Surgery: Any operation removing part of the pancreas reduces enzyme output proportionally. Whipple, distal pancreatectomy, total pancreatectomy. Post-surgical PEI is basically guaranteed after major resection. Lifelong replacement from day one, no question about it. Diabetes: This one surprises people. Long-standing Type 2 diabetes is associated with PEI in 30 to 50% of patients in some studies. Most endocrinologists don’t screen for it. Diabetic patient with unexplained bloating, oily stools, weight dropping, gets told to fix their diet when a fecal elastase would have given the answer in two days. Causes overlap in the same patient more often than you’d expect. Specialist in pancreatitis treatment finds out what broke the enzyme production rather than just handing over capsules without asking why. How Is PEI Diagnosed and Treated? Diagnosis takes one test. Treatment takes one medication. The problem is neither happens for months because nobody considers the pancreas until everything else has been tried first. Fecal Elastase: Stool sample. Result in 48 hours. Below 200 is moderate. Below 100 is severe. That’s it. One test. Would have saved the patient months of elimination diets, probiotics, and frustration if someone had ordered it at the first appointment. PERT: Enzyme replacement capsules with every meal and snack. Start at 40,000 to 50,000 units lipase per main meal, 25,000 per snack. Most patients feel genuinely different within 2 to 4 weeks. Stools normalise. Bloating drops. Weight starts recovering. They ask why nobody started this sooner. Vitamins: A, D, E, K can’t absorb without lipase. Check levels. Supplement what’s low. Patient comes in with bone pain from D deficiency, bruising from K, fatigue nobody explained. Put those findings next to oily stools and weight loss and the diagnosis writes itself. Cause: PERT fixes the symptom. Doesn’t fix the patient. Chronic pancreatitis needs managing. Cancer needs ruling out. Surgical patients need monitoring. Enzyme capsules without investigating why the pancreas stopped working is like treating a fever without looking for the infection. PEI responds to treatment quickly when diagnosed properly. Read more on enzyme deficiency signs to understand which specific symptoms should trigger testing and how dose titration works in real clinical practice. Why Choose Dr. Vipulroy Rathod for Pancreatic Exocrine Insufficiency? Dr. Vipulroy Rathod has spent over 30 years diagnosing pancreatic disease at Fortis Hospital Mulund. Caught PEI in patients labelled IBS for years because one fecal elastase test hadn’t been ordered. EUS since 1998 means the underlying cause gets identified in the same workup, not six months later. 35 countries worth of physicians trained in this approach. Patients arrive having tried everything except the right test. Most leave with enzyme replacement working within weeks, a diagnosis for why it happened, and a plan that actually addresses both.   Book your consultation today with one of India’s most experienced specialists for pancreatic exocrine insufficiency diagnosis and treatment. Book Appointment Call now Frequently Asked Questions What is the most common cause of pancreatic exocrine insufficiency? Chronic pancreatitis is the most common cause of PEI in adults, destroying enzyme-producing tissue through repeated inflammation over years. How is PEI diagnosed? Fecal elastase test on a stool sample is the standard non-invasive diagnostic method, with levels below 200 indicating PEI. Is PEI the same as pancreatic enzyme deficiency? Yes, PEI and pancreatic enzyme deficiency describe the same condition where the pancreas fails to produce adequate digestive enzymes. Can PEI be cured permanently? PEI from chronic pancreatitis or surgery is usually permanent and requires lifelong enzyme replacement, while PEI from reversible causes may improve with treatment of the underlying condition. Reference links- Pancreatic Exocrine Insufficiency Diagnosis — American College of Gastroenterology PEI Management Guidelines — World Gastroenterology Organisation

Pancreatic enzyme deficiency, or EPI, is what happens when the pancreas can’t produce enough lipase, protease, and amylase to digest food the way it should. Usually chronic pancreatitis behind it, sometimes cancer, sometimes surgery that took part of the organ out. Fat passes through unabsorbed, protein the same, patient drops weight, stools turn oily and foul, bloating after every meal, and the whole thing gets labelled IBS or food intolerance for months because nobody ordered a fecal elastase. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Pancreatic enzyme deficiency is one of those conditions where patients suffer with digestive symptoms for a long time before anyone thinks to test pancreatic function, and by the time we see them most have already lost significant weight and developed nutritional deficiencies that could have been prevented.” What Are the Signs of Pancreatic Enzyme Deficiency? Looks like IBS on paper. Feels like IBS to the patient. But test the pancreas and the picture changes completely. Steatorrhoea: Oily pale stools that float and won’t flush. Fat malabsorption, plain and simple. Patients describe dealing with this for years while being told it’s dietary, and one fecal elastase test would have given the answer months ago. Weight: Dropping weight despite eating normally or more. Fat and protein passing through unabsorbed no matter how much goes in. Patient gets told to eat better. Nobody measures enzyme output. The gap between what’s eaten and what’s absorbed keeps widening. Bloating: Worse after fatty meals. Undigested fat fermenting in the gut. Gets managed with antacids, probiotics, elimination diets, everything except the one test that would explain it, and meanwhile the malabsorption continues unchecked. Deficiencies: Vitamins A, D, E, K need lipase for absorption. Without it you get bone pain from D deficiency. Easy bruising from K. Fatigue nobody can explain on routine bloods. Connect those back to the pancreas and suddenly the whole picture makes sense. These matter more when there’s pancreatitis history, prior surgery, or diabetes that appeared without obvious metabolic reason. Specialist in pancreatitis treatment tests pancreatic function as part of the workup rather than chasing individual symptoms separately. How Is Pancreatic Enzyme Deficiency Treated? Diagnosis is the hard part. Treatment is straightforward. Most patients improve within weeks once someone finally gets the diagnosis right. PERT: Enzyme replacement capsules with every meal and snack. Lipase, protease, amylase in one capsule. Stool quality improves within 2 to 4 weeks at the right dose. Bloating drops. Weight starts coming back. Most patients say they wish someone had started this a year ago. Dosing: 40,000 to 50,000 units lipase per main meal. 25,000 per snack. Symptoms don’t improve? Increase the dose. Not switch medications. Not stop PERT. Increase. Most patients we see are underdosed because nobody titrated properly after the initial prescription. Diet: Old textbooks said cut fat. Wrong approach for a malnourished patient. Current practice is normalise fat intake, adjust PERT dose to match, because restricting calories in someone already losing weight from months of malabsorption makes the problem worse not better. Monitoring: Check fat-soluble vitamins. Supplement what’s low. Track weight monthly. Repeat fecal elastase. And manage the underlying cause, pancreatitis, cancer, surgical, alongside the enzyme replacement rather than running two separate treatment tracks in two separate clinics that don’t talk to each other. Treatment works. Getting to the diagnosis is where most patients lose time. Read more on metabolic connections to understand how pancreatic dysfunction ties into broader metabolic problems that need managing together rather than in isolation. Why Choose Dr. Vipulroy Rathod for Pancreatic Enzyme Deficiency? Dr. Vipulroy Rathod has spent over 30 years managing pancreatic disease at Fortis Hospital Mulund. Diagnosed exocrine insufficiency in patients labelled IBS for years. EUS since 1998, underlying cause identified alongside the enzyme deficiency every time. 35 countries worth of physicians trained in this approach. Patients arrive malnourished, frustrated, undiagnosed. Most leave with enzyme replacement at the right dose, a clear explanation for symptoms nobody else investigated, and a plan that actually addresses both the deficiency and whatever caused it.   Book your consultation today with one of India’s most experienced specialists for pancreatic enzyme deficiency diagnosis and management. Book Appointment Call now Frequently Asked Questions What causes pancreatic enzyme deficiency? Chronic pancreatitis is the most common cause, followed by pancreatic cancer, cystic fibrosis, and pancreatic surgery that removes enzyme-producing tissue. How is pancreatic enzyme deficiency diagnosed? Fecal elastase test is the most common non-invasive method, with levels below 200 indicating moderate deficiency and below 100 indicating severe. Can pancreatic enzyme deficiency be cured? The underlying cause determines whether it’s reversible, but most cases require lifelong enzyme replacement therapy to manage symptoms and prevent malnutrition. What happens if pancreatic enzyme deficiency is left untreated? Untreated EPI leads to progressive malnutrition, fat-soluble vitamin deficiencies, osteoporosis, weight loss, and significantly reduced quality of life. Reference links- Exocrine Pancreatic Insufficiency Guidelines — American College of Gastroenterology Pancreatic Enzyme Replacement Therapy — World Gastroenterology Organisation

Endoscopic ultrasound puts a high-frequency ultrasound probe on the tip of a flexible endoscope and images organs from inside the GI tract, millimetres from the target rather than through layers of skin and fat from outside. It’s needed when CT or MRI can’t give a clear answer, when deep tissue biopsy is required without surgery, or when cancer staging depends on detail external imaging consistently misses. We use it because it sees what other scans don’t, and in pancreatic, biliary, and upper GI disease that difference changes treatment decisions regularly. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “EUS is the investigation that closes the gap between what CT shows and what’s actually there, and in pancreatic, oesophageal, and gastric disease that gap is often the difference between the right treatment plan and the wrong one.” What Is EUS and How Does It Work? Standard endoscopy looks at the surface. EUS looks through the wall and beyond. Not a small difference when you need to know what’s happening in the pancreas or inside a lymph node CT flagged but couldn’t characterise. Mechanism: Ultrasound transducer on the scope tip, positioned inside the stomach or duodenum, images wall layers, lymph nodes, vessels, and adjacent organs at 5 to 12 MHz frequencies, resolution that shows individual tissue layers CT physically cannot distinguish from the outside. Biopsy: Needle passes through the GI wall into a pancreatic mass, lymph node, or submucosal lesion under real-time ultrasound guidance, no external incision, tissue result often changes the entire treatment plan because imaging alone can suggest but biopsy confirms. Procedure: Sedation, scope through the mouth into stomach or duodenum for upper EUS, through rectum for rectal staging, 30 to 60 minutes total, home same day, and most patients are surprised it was less involved than they expected going in. Safety: Complication rate under 1% for diagnostic EUS, 1 to 2% for FNA, serious events like perforation are rare when someone experienced is doing it, and the information gained almost always outweighs the small procedural risk in patients where EUS is genuinely indicated. EUS delivers information no other single investigation provides in one session. Specialist in endoscopic ultrasound uses it as the primary tool for conditions where it genuinely changes what happens next. When Is EUS Actually Needed? Not for every GI complaint. Specific decision points where its accuracy changes the management plan. Outside those, it’s not the right investigation. Pancreatic: Any pancreatic mass, cyst, or suspected cancer needs EUS because CT misses sub-2 cm tumours routinely, and if you’ve had persistent upper abdominal symptoms with a normal CT that doesn’t explain them, EUS is where the answer usually sits rather than another round of the same scan. Staging: Confirmed oesophageal, gastric, pancreatic, or rectal cancer needs EUS for T and N staging because tumour depth and nodal involvement measured on EUS consistently outperform CT, and getting the stage wrong means the patient ends up on a treatment pathway that doesn’t match their actual disease. Submucosal: Lumps found underneath the surface on routine endoscopy, GISTs, leiomyomas, carcinoid tumours, need EUS to characterise layer of origin, size, and internal features before anyone decides whether to remove or watch, and standard endoscopy alone cannot make that call. Biliary: Bile duct stones missed on ultrasound, suspected bile duct cancer, ampullary tumours, all evaluated more accurately on EUS than external imaging, and EUS-guided FNA of bile duct masses gives tissue diagnosis that ERCP brushings miss in a meaningful proportion of cases. EUS earns its place when the answer genuinely matters for treatment. Read more on EUS in pancreatic cancer to see how it changes diagnosis and staging decisions specifically in pancreatic disease. Why Choose Dr. Vipulroy Rathod for Endoscopic Ultrasound? Dr. Vipulroy Rathod has been performing diagnostic and therapeutic EUS since 1998 at Fortis Hospital Mulund. Over 30 years of case volume across pancreatic, biliary, oesophageal, gastric, and rectal EUS. First Indian to receive the FASGE fellowship. 35 countries worth of physicians trained in EUS technique and clinical interpretation. Patients arrive with inconclusive CT reports and months of unanswered questions. Most leave with a finding, a tissue diagnosis, and a clear next step nobody else had been able to provide.   Book your consultation today with one of India’s most experienced EUS specialists for accurate diagnosis and intervention. Book Appointment Call now Frequently Asked Questions What is the difference between EUS and regular endoscopy? Regular endoscopy sees the surface lining while EUS images through the wall and surrounding structures using ultrasound for deeper diagnostic detail. Is EUS painful? EUS is performed under sedation and most patients experience minimal discomfort during and after the procedure. Can EUS detect cancer that CT missed? Yes, EUS detects pancreatic and GI tract lesions under 2 cm that CT regularly misses and provides tissue biopsy in the same session. How long does an EUS procedure take? EUS with or without biopsy typically takes 30 to 60 minutes including sedation and recovery time. Reference links- Endoscopic Ultrasound Indications and Guidelines — American Society for Gastrointestinal Endoscopy EUS in GI Disease Diagnosis — World Gastroenterology Organisation

Pancreatic cancer risk factors include smoking, long-standing diabetes, obesity, chronic pancreatitis, family history, certain gene mutations like BRCA2 and PALB2, these are the big ones. Most patients we diagnose carried two or three of these for years and nobody put them together into a risk picture that warranted investigation. That gap between having identifiable risk factors and someone actually acting on them is where most late diagnoses come from. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Most patients diagnosed with pancreatic cancer had at least two identifiable risk factors that nobody connected together early enough to trigger proper investigation, and that pattern repeats itself in clinical practice far more often than it should.” What Are the Major Risk Factors for Pancreatic Cancer? Some you can change. Some you can’t. But knowing what you carry changes how seriously vague symptoms should be taken when they show up. Smoking: Doubles lifetime risk, roughly. About 25% of all pancreatic cancers trace back to this. Even after quitting the risk stays elevated for 10 to 15 years before it starts coming down, so if you smoked for 20 years and quit 5 years ago and now you have persistent upper abdominal pain, you’re not in the same category as someone who never touched a cigarette. Diabetes: Two different stories here. Long-standing Type 2 carries elevated risk through years of insulin resistance. But new onset diabetes after 50 in someone who isn’t overweight and has no metabolic reason for it, that’s a red flag most doctors miss because they start metformin and move on without ever imaging the pancreas to check what’s actually going on underneath. Obesity: BMI above 30 bumps up risk by 20 to 30%. Visceral fat drives the link through inflammatory mediators that damage tissue over time. Stack central obesity with diabetes and smoking in the same patient and you’ve got a compounded risk profile that nobody mentions during a routine check-up because nobody is thinking about the pancreas. Pancreatitis: Chronic pancreatitis raises lifetime risk 8 to 10 fold. Hereditary pancreatitis goes higher still. Problem is, pancreatitis pain and early pancreatic cancer pain feel identical to the patient, so the cancer hides inside a condition that already explains the symptoms. These rarely exist alone. Most patients carry two or three. A pancreatic cancer treatment specialist maps the full profile and decides investigation thresholds from there. What About Genetic and Family Risk? Not all pancreatic cancer is random. Around 10% have a hereditary component and these families need a completely different approach to surveillance. Family: One first-degree relative with pancreatic cancer, roughly double your risk. Two or more, 6 to 12 times baseline. These patients should be on annual EUS from age 50 or 10 years before the youngest family diagnosis, whichever hits first, and most of them have never been told this. BRCA2: 3 to 10 fold elevated risk depending on family history. Structured EUS surveillance catches small lesions before they produce symptoms. If you know you carry BRCA2 and nobody has mentioned pancreatic screening, that’s a conversation you need to start yourself because it won’t come to you automatically. PALB2: Less talked about than BRCA2 but the pancreatic cancer risk is comparable. Same surveillance category, same annual EUS, same urgency. Most PALB2 carriers have no idea pancreatic screening should even be on their radar. Lynch: Mismatch repair gene mutations. Usually these patients are already in surveillance for colorectal and endometrial cancer. Adding pancreatic screening to the same programme makes clinical sense. Rarely happens in practice though. Genetic risk changes when surveillance starts and how aggressive it should be. Read more on detection to understand why finding this cancer before symptoms develop is the only approach that consistently changes what happens next for high-risk patients. Why choose Dr. Vipulroy Rathod to identify and avoid pancreatic cancer risk factors ? Dr. Vipulroy Rathod has spent over 30 years at Fortis Hospital Mulund managing pancreatic disease through EUS, fine needle aspiration, and structured high-risk surveillance. Risk factors sitting unconnected in patient records for years, finally mapped into a proper surveillance plan. Small lesions found in patients whose prior workups had missed the pancreas entirely. 35 countries worth of physicians trained in this specific approach. Most patients walk in having never been told their combination of risk factors warranted active screening. Many walk out with a programme that actually watches for this cancer before it decides to announce itself.   Book your consultation today with one of India’s most experienced specialists for identifying risk factors and avoid pancreatic cancer. Book Appointment Call now Frequently Asked Questions Does smoking increase pancreatic cancer risk? Yes, smoking roughly doubles lifetime pancreatic cancer risk and accounts for approximately 25% of all cases. Can diabetes be an early sign of pancreatic cancer? New onset diabetes after 50 in a non-obese patient with no metabolic risk factors can be an early signal of underlying pancreatic cancer. Who should get screened for pancreatic cancer? BRCA2 and PALB2 carriers, patients with familial pancreatic cancer, hereditary pancreatitis, and Lynch syndrome benefit most from structured EUS surveillance. Does chronic pancreatitis increase pancreatic cancer risk? Yes, chronic pancreatitis increases lifetime pancreatic cancer risk 8 to 10 fold and hereditary pancreatitis raises it even further. Reference links- Pancreatic Cancer Risk Factor Guidelines — American Society for Gastrointestinal Endoscopy Hereditary Pancreatic Cancer Surveillance — World Gastroenterology Organisation

Pancreatic cancer is difficult to detect early because the pancreas is located deep in the abdomen, preventing small, early-stage tumours from being felt during exams or easily seen on imaging. Additionally, symptoms are vague, such as indigestion or mild back pain, mimicking other conditions, and often do not appear until the tumour has grown or spread. By the time most patients receive a diagnosis, the cancer has already moved past the stage where surgical cure was still a realistic option. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Pancreatic cancer hides because of its anatomy and because its early signals are exactly the kind nobody investigates aggressively until something dramatic forces the issue, which is usually too late to change the outcome.” Why Does This Cancer Stay Hidden So Long? Not one reason. Several, all working together, and the combination is what makes pancreatic cancer different from most other GI cancers. Anatomy: Pancreas tucked behind the stomach, surrounded by bowel loops and fat, ultrasound barely reaches it properly and CT misses tumours under 2 cm more often than most patients or their doctors realise. Symptoms: Upper abdominal discomfort, mild back pain, appetite dropping off, slow weight loss. Every single one of these gets blamed on something else, acidity, gastritis, work stress, ageing, for months before anyone even considers the pancreas. Diabetes: New diabetes after 50 in someone who isn’t overweight and has no metabolic history. That’s a red flag. But most doctors start metformin and move on without ever ordering a pancreatic scan, and the tumour keeps growing while the blood sugar gets managed as a standalone problem. No Screening: Colonoscopy catches colorectal cancer early. Mammography catches breast cancer early. Pancreatic cancer has nothing equivalent, so unless a patient is already in a high-risk surveillance programme, nobody is looking until symptoms force the conversation. These factors reinforce each other in ways that keep pushing diagnosis later, and specialist in pancreatic cancer treatment uses EUS whenever clinical suspicion exists rather than waiting for CT to eventually declare something that should have been found months earlier. How Do You Actually Catch It Early? Right investigation. Right patient. Right timing. Not hoping the next scan shows what the last one missed. EUS: Imaging probe positioned millimetres from the pancreas through the stomach wall. Picks up sub-2 cm tumours CT misses. Biopsy in the same session. This is the most effective early detection tool available and the reason patients with inconclusive CT findings should be moving toward EUS, not repeating the same scan again. Surveillance: BRCA2 carriers, first-degree relatives of pancreatic cancer patients, hereditary pancreatitis. All need annual EUS. Finding a small lesion before symptoms develop is the only proven way to catch this cancer at genuinely curable stage in people with genetic predisposition. Symptom Clusters: Persistent upper abdominal pain plus unexplained weight loss. New diabetes after 50 plus painless jaundice. Any combination of these in the same patient over a short period warrants EUS, not another round of acid suppression and a follow-up appointment in six weeks. Next Step: CT inconclusive or symptoms persisting despite normal scans. EUS should be the immediate next investigation. Not a repeat CT in three months. Three months of pancreatic cancer growth is exactly the kind of delay that changes a resectable tumour into an unresectable one. Catching pancreatic cancer early requires the right tool at the right decision point, not luck. Read more on warning signs to understand which specific signals deserve aggressive investigation and which patient profiles need a much lower threshold for imaging than the general population. Why choose Dr. Vipulroy Rathod to detect pancreatic cancer ? Dr. Vipulroy Rathod has spent over 30 years catching pancreatic cancer through EUS, fine needle aspiration, and structured high-risk surveillance at Fortis Hospital Mulund. Small resectable tumours in patients whose CT scans had been called normal. Diagnoses made where other pathways had stopped looking. Physicians from 35 countries trained in this specific approach. Most patients arrive after months of reassurance that nothing was wrong, and many leave with a real diagnosis caught early enough to actually treat. That gap between reassurance and reality is exactly what proper investigation closes.   Book your consultation today with one of India’s most experienced specialists for detecting pancreatic cancer. Book Appointment Call now Frequently Asked Questions Why does pancreatic cancer get diagnosed so late? The pancreas sits deep in the abdomen, early symptoms are vague, and no routine screening exists outside high-risk patient groups. Can pancreatic cancer be detected before symptoms develop? Yes, EUS surveillance can find small pancreatic lesions in high-risk patients before any symptoms appear. Is CT scan enough to detect pancreatic cancer early? No, CT often misses pancreatic tumours under 2 cm and EUS is required for accurate early detection in most cases. Who should get EUS surveillance for pancreatic cancer? BRCA2 carriers, patients with familial pancreatic cancer, and those with hereditary pancreatitis benefit most from annual EUS surveillance. Reference links- Pancreatic Cancer Early Detection Challenges — American Society for Gastrointestinal Endoscopy Pancreatic Cancer Surveillance Guidelines — World Gastroenterology Organisation

EUS is the most accurate single tool we have for diagnosing pancreatic cancer because the imaging probe sits within millimetres of the pancreas, picking up tumours under 2 cm that CT and MRI miss while letting us biopsy the same lesion in the same session. It changed pancreatic cancer diagnosis fundamentally because external scans on their own simply cannot deliver the kind of detail or tissue sampling early-stage decisions actually depend on. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “EUS is not just another imaging option in pancreatic cancer, it is often the difference between catching a small resectable tumour and finding the same disease six months later when the window for cure has already closed.” What Role Does EUS Play in Pancreatic Cancer Diagnosis? EUS does several things in one session that no other modality can deliver together, which is exactly why it sits at the centre of how pancreatic cancer actually gets diagnosed in practice. Detection: EUS picks up pancreatic lesions under 2 cm with sensitivity that consistently beats CT and MRI for small tumours, finding disease at the stage where surgical resection still offers a real chance of cure rather than catching it months later when the options have already started narrowing. Biopsy: EUS-guided fine needle aspiration samples the tumour directly through the stomach or duodenal wall in the same session as imaging, which matters because pancreatic cancer treatment is far too aggressive to start without proper biopsy proof and external scans can only suggest rather than confirm what’s there. Cysts: EUS evaluates pancreatic cystic lesions and tells benign serous cysts apart from premalignant mucinous cysts and IPMNs through fluid sampling and morphology assessment, picking up subtle features CT cannot show and changing surveillance decisions in a meaningful percentage of patients. Vessels: EUS shows the relationship between tumour and major vessels with millimetre accuracy that decides surgical resectability, which is why patients who looked unresectable on CT sometimes turn out to be operable after EUS clarifies what’s actually happening at the vascular interface. EUS gives information no external scan can replicate, and specialist in endoscopic ultrasound treats it as the primary diagnostic tool rather than an optional add-on after CT and MRI have already finished guessing. When Should EUS Be Used in the Pancreatic Cancer Workup? EUS belongs in the workup at specific decision points where its accuracy genuinely changes the management plan, not as a routine box-tick for every patient walking through the door. Suspicion: Patients with worrying symptoms and inconclusive CT or MRI findings need EUS to either confirm or rule out pancreatic disease, because vague upper abdominal pain alongside a normal external scan still leaves the question wide open and the only way to close it properly is direct visualisation. Cysts: Any pancreatic cyst found incidentally on CT or MRI deserves EUS evaluation to characterise it accurately, because surveillance decisions hinge on cyst type and external scans cannot reliably tell the benign cysts from the ones with real malignant potential underneath. Staging: Confirmed pancreatic cancer needs EUS-based staging alongside CT and MRI because tumour size, vascular involvement, and nodal disease all get measured more accurately on EUS, which directly affects whether surgery, neoadjuvant chemotherapy, or palliative care becomes the right pathway. High Risk: BRCA2 carriers, patients with familial pancreatic cancer history, and those with hereditary pancreatitis benefit from annual EUS surveillance because finding small lesions before symptoms develop is the only realistic way to catch this cancer at curable stage in genetically predisposed patients. EUS earns its place in pancreatic cancer workup at every point where the answer actually matters for treatment. Read more on neurolysis to see how the same EUS technology delivers therapeutic intervention beyond just diagnosis when disease is already advanced. Why choose Dr. Vipulroy Rathod to understand the role of EUS in diagnosis of pancreatic cancer ? Dr. Vipulroy Rathod has spent over 30 years performing diagnostic and therapeutic EUS in pancreatic disease at Fortis Hospital Mulund, finding small resectable tumours that external scans had labelled normal and providing tissue diagnosis that changed the entire treatment plan for patients whose CT findings stayed inconclusive, and has trained physicians from 35 countries in this exact diagnostic pathway. Most patients arrive having been told something pancreatic was uncertain on CT, and many leave with a clear answer based on EUS imaging and biopsy that either confirmed cancer at a stage where treatment still works or ruled it out properly so the search could continue elsewhere instead of getting stuck in repeat scans that never settle the question.   Book your consultation today with one of India’s most experienced specialists for understanding EUS diagnosis for pancreatic cancer  Book Appointment Call now Frequently Asked Questions Is EUS more accurate than CT for pancreatic cancer diagnosis? Yes, EUS detects pancreatic tumours under 2 cm and provides tissue biopsy in the same session, outperforming CT for small lesion detection. Can EUS confirm pancreatic cancer diagnosis? Yes, EUS-guided fine needle aspiration provides histological tissue confirmation that is essential before starting any pancreatic cancer treatment. Is EUS painful for pancreatic cancer evaluation? EUS is performed under sedation and patients typically experience minimal discomfort during and after the procedure. How long does an EUS procedure for pancreatic cancer take? EUS with fine needle biopsy for pancreatic cancer typically takes 30 to 60 minutes including sedation and recovery time. Reference links- EUS in Pancreatic Cancer Diagnosis — American Society for Gastrointestinal Endoscopy Pancreatic Cancer EUS Guidelines — World Gastroenterology Organisation